Is prospective MRI mapping of the changes in the volume of the prostate gland in prostate cancer patients undergoing 6 months of neo-adjuvant androgen deprivation therapy a step towards a trial to determine those who may benefit from treatment intensification or extended duration?

David R.H. Christie*, Christopher F. Sharpley, Natalia Mitina, Eamonn MacAteer, James E. Jackson, Dominic Lunn

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Is prospective MRI mapping of the changes in the volume of the prostate gland in prostate cancer patients undergoing 6 months of neo-adjuvant androgen deprivation therapy a step towards a trial to determine those who may benefit from treatment intensification or extended duration?'. Together they form a unique fingerprint.

Medicine & Life Sciences